Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 414

Results For "Global"

4806 News Found

Complement Therapeutics raises €5 million seed financing
News | February 23, 2022

Complement Therapeutics raises €5 million seed financing

Appoints Dr Rafiq Hasan as CEO


Biorchestra announces US$45 million series C fundraising
News | February 23, 2022

Biorchestra announces US$45 million series C fundraising

he financing was significantly oversubscribed with high demand from both existing and new investors.


Moderna and Thermo Fisher Scientific to deepen mRNA collaboration
Medical Device | February 23, 2022

Moderna and Thermo Fisher Scientific to deepen mRNA collaboration

The 15-year agreement will leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies


WHO establishes biomanufacturing training hub in South Korea
News | February 23, 2022

WHO establishes biomanufacturing training hub in South Korea

Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub


AstraZeneca partners with Honeywell to develop next-gen respiratory inhalers
Sustainability | February 22, 2022

AstraZeneca partners with Honeywell to develop next-gen respiratory inhalers

New inhalers would have near-zero Global Warming Potential propellant


Biosion appoints Joel Edwards as Chief Business Officer
People | February 22, 2022

Biosion appoints Joel Edwards as Chief Business Officer

Prior to joining Biosion, Edwards was Vice President of Corporate Strategy and operations at Ionis Pharmaceuticals.


Formulated Solutions appoints John Maddox as COO
People | February 22, 2022

Formulated Solutions appoints John Maddox as COO

John served as General Manager for Catalent Pharma Solutions in St. Petersburg, Florida


CARsgen Therapeutics opens new U.S. cGMP facility for CAR T production
News | February 22, 2022

CARsgen Therapeutics opens new U.S. cGMP facility for CAR T production

The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe


Prestige BioPharma’s facility receives EU-GMP certification
Biotech | February 22, 2022

Prestige BioPharma’s facility receives EU-GMP certification

The facility will manufacture its Herceptin biosimilar, Tuznue